Sep 2026· Current Microbiology· Vol 83· 0 citations· 45 references
Medicine
TL;DR
It seems that the infected male mice with the recent SARS-CoV-2/2025 could suffer from milder clinical signs than the infected female mice because of the increased expression of immune-enhancing cytokines and anti-apoptotic genes.
The reduced pathogenicity of rSARS-CoV-2 Nsp1 mutants highlights the potential for targeting Nsp1 for rational design of viral inhibitors and development of live-attenuated vaccine strategies as effective prophylactic and therapeutic treatments to combat SARS-CoV-2 and possibly other CoV infections.
ABSTRACT In immunocompromised patients, persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries the risk of prolonged viral shedding and emergence of new variants. To reproduce the key features of persistent SARS-CoV-2 infection and evaluate its transmissibility, mouse-passaged SARS-Co...
Kaya Miyazaki, Nozomi Shiwa-Sudo, N. Iwata-Yoshikawa et al.· Microbiology spectrum· 0 citations
Introduction Mycobacterium tuberculosis infects nearly a quarter of the world population, while SARS-CoV-2 has infected hundreds of millions in recent years. The cellular and genetic impact of this coinfection remains unclear. Methods Using a murine model, we studied SARS-CoV-2 superinfection during acute and chronic s...
Rachel E. Hildebrand, Madeleine B. Lodes, S. Chandrasekar et al.· Frontiers in Immunology· 0 citations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), can infect a broad range of mammalian species, including companion animals. Early reports during 2020 established that cats and dogs can acquire SARS-CoV-2, particularly after close contact with inf...
M. Al-Farwachi, B. Albadrani, Q. T. Al-Obadi et al.· Applied Veterinary Research· 0 citations
The infant mouse model is used to define the role of the accessory protein ORF8 in SARS-CoV-2 spread and reveal how a SARS-CoV-2 accessory protein can exploit mucosal antiviral responses to increase host contagiousness.
G. Ciabattoni, Stacey Bartlett, M. McGrath et al.· bioRxiv· 0 citations
ABSTRACT Yezo virus (YEZV) is an emerging tick-borne orthonairovirus that causes febrile illness and hepatic injury in humans. However, its pathogenesis and effective antiviral interventions remain poorly characterized. In this study, we generated a lethal, mouse-adapted YEZV strain through 30 serial passages in C57BL/...
Yu Liu, Ning Liu, Ge-Lin Zhang et al.· Emerging Microbes and Infect...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.